PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Review Article

Volume 8 Issue 6

Modern and Greco-Arabic Management of Chronic Kidney Diseases (CKD): A Scientific Analysis

Mohammad Nazrul Islam*

June 09, 2026

Abstract

Chronic Kidney Disease (CKD) is a progressive condition characterized by a gradual decline in kidney function, leading to the accumulation of metabolic waste and fluid imbalance. The leading cause of CKD is persistent hyperglycemia due to diabetes mellitus. High blood glucose levels damage renal microvasculature, particularly the glomeruli, resulting in proteinuria. Hyperfiltration, intraglomerular hypertension, and the formation of advanced glycation end products (AGEs) further exacerbate renal injury through inflammation, fibrosis, and vascular damage. Hypertension, often coexisting with diabetes, accelerates CKD progression by increasing intrarenal pressure and perpetuating a cycle where elevated blood pressure and renal dysfunction worsen each other. This vicious cycle significantly heightens the risk of cardiovascular events, including myocardial infarction and stroke.

In the Greco-Arabic (Unani) medicine, CKD is described as a chronic imbalance in the body’s humors (Akhlat)—particularly involving a derangement of the kidneys' cold and moist temperament (Mizaj). Conditions such as Zauf-e-Kulya (renal weakness), Daffe-e-Baul ka ikhtilal (urinary dysfunction), and Istisqa (dropsy) accentuate the manifestations of CKD. Scholars like Hippocrates, Galen, and Avicenna emphasized the role of humoral imbalance and renal purification in systemic health. Avicenna notably linked Fasad-e-Mizaj (temperamental derangement) with renal dysfunction and advised dietary regulation and herbal interventions (Muqawwi-e-Kilya) for prevention and management of CKD. This integrated perspective highlights the importance of understanding CKD both through modern pathophysiological mechanisms and traditional holistic frameworks for comprehensive care.

Keywords: Chronic Kidney Disease (CKD); Advanced Glycation End Products (AGEs); Humoral Imbalance; Dietary intervention and Greco-Arabic management

References

  1. Anand S., et al. “High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: A cross-sectional study”. Globalization and Health 10.1 (2014): 9.
  2. Das S and Dutta PK. “Chronic kidney disease prevalence among health care providers in Bangladesh”. Mymensingh Medical Journal 19.3 (2010): 415-421.
  3. Eneyew TF., et al. “Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide: A systematic review and meta-analysis”. Diabetology & Metabolic Syndrome 15.1 (2023): 245.
  4. Hill NR., et al. “Global prevalence of chronic kidney disease: A systematic review and meta-analysis”. PLoS ONE 11.7 (2016): e0158765.
  5. Huda MN., et al. “Prevalence of chronic kidney disease and its association with risk factors in disadvantageous population”. International Journal of Nephrology (2012): 267329.
  6. Mills KT., et al. “A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010”. Kidney International 88.5 (2015): 950-957.
  7. Sarker MHR., et al. “Community-based screening to determine the prevalence, health and nutritional status of patients with CKD in rural and peri-urban Bangladesh”. Therapeutic Advances in Chronic Disease 12 (2021): 20406223211035281.
  8. Stanifer JW., et al. “Chronic kidney disease in low- and middle-income countries”. Nephrology Dialysis Transplantation 31.6 (2016): 868-874.